Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,451 public trials 168 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

NCT00443391

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Site Reference ID/Investigator# 6109 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 6765 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 6100 Lafayette, California, United States
  • Site Reference ID/Investigator# 6107 San Diego, California, United States
View all 21 locations
View Trial Details
Completed

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00640185

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Site Reference ID/Investigator# 7546 Lafayette, California, United States
  • Site Reference ID/Investigator# 7551 Jacksonville, Florida, United States
  • Site Reference ID/Investigator# 7553 Orlando, Florida, United States
  • Site Reference ID/Investigator# 7545 Overland Park, Kansas, United States
View Trial Details
Completed

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00640419

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Site Reference ID/Investigator# 7536 Little Rock, Arkansas, United States
  • Site Reference ID/Investigator# 7954 Bradenton, Florida, United States
  • Site Reference ID/Investigator# 7543 Jacksonville, Florida, United States
  • Site Reference ID/Investigator# 7542 Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

Atomoxetine and Huntington's Disease

NCT00368849

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Basal Ganglia Diseases, +19 more
Locations
  • The University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder

NCT00969618

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
View Trial Details

Related conditions